These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6730017)

  • 1. Prognostic evaluation of estrogen receptors and urinary androgens in ovariectomy for advanced breast cancer.
    Oriana S; Scavone G; Böhm S; Di Fronzo G; Preda F
    Tumori; 1984 Apr; 70(2):185-7. PubMed ID: 6730017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary androgens and tumor estrogen receptor as predictors of ovariectomy response and of survival in advanced breast cancer.
    Oriana S; Secreto G; Di Fronzo G; Torri A
    Breast Cancer Res Treat; 1987; 9(3):201-5. PubMed ID: 3663955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion.
    Oriana S; Secreto G; Severini A; Di Fronzo G; Di Giuseppe M; Valagussa P; Preda F
    Breast Cancer Res Treat; 1982; 2(1):101-4. PubMed ID: 7171833
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete remission after ovariectomy for advanced breast cancer correlated with estrogen receptor status and urinary androgen excretion.
    Oriana S; Secreto G; Di Fronzo G; Böhm S; Torri A
    Breast Cancer Res Treat; 1988 Dec; 12(3):303-5. PubMed ID: 3228592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between clinical response to bilateral oophorectomy, estrogen receptors and urinary androgen excretion in 49 patients with advanced breast cancer.
    Preda F; Pizzocaro G; Oriana S; Riboldi G; Severini A; Di Fronzo G; Secreto G; Grattarola R
    Tumori; 1979 Jun; 65(3):325-30. PubMed ID: 462582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survival.
    Mason BH; Holdaway IM; Skinner SJ; Kay RG
    Breast Cancer Res Treat; 1994; 32(2):203-12. PubMed ID: 7865850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term response to ovariectomy in 35 premenopausal patients with advanced breast cancer, treated in coherence with hormonal tests.
    Preda F; Oriana S; Di Fronzo G; Secreto G; Severini A; Scavone G; Castagnola G
    Tumori; 1983 Aug; 69(4):343-7. PubMed ID: 6623658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptors in primary breast cancer.
    Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
    Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A relationship between artifical menopause, previous estrogen consumption, and estrogen receptor content of breast neoplasms: preliminary communication.
    Wallace RB; Sherman BM; Bean JA
    Oncology; 1980; 37(2):111-3. PubMed ID: 7360478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine kinase as a predictor of response to chemotherapy in advanced breast cancer.
    Zhang HJ; Kennedy BJ; Kiang DT
    Breast Cancer Res Treat; 1984; 4(3):221-5. PubMed ID: 6487823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen receptors and breast cancer: current status.
    Hawkins RA; Roberts MM; Forrest AP
    Br J Surg; 1980 Mar; 67(3):153-69. PubMed ID: 6988031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of estrogen and progesterone receptors in breast cancer.
    McGuire WL; Horwitz KB; Pearson OH; Segaloff A
    Cancer; 1977 Jun; 39(6 Suppl):2934-47. PubMed ID: 326386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between estrogen receptor levels and clinical response to ovariectomy in premenopausal women with advanced breast cancer.
    Oriana S; Riboldi GL; Böhm S; Baeli A; Sasso GM; Oriana V
    Eur J Surg Oncol; 1986 Dec; 12(4):343-6. PubMed ID: 3536581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles and indications of endocrine treatment of advanced breast cancer.
    Mouridsen HT; Palshof T
    Recent Results Cancer Res; 1980; 71():112-7. PubMed ID: 7367722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)].
    Maass H; Jonat W
    Arch Geschwulstforsch; 1981; 51(7):623-9. PubMed ID: 7337544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast.
    Paone JF; Abeloff MD; Ettinger DS; Arnold EA; Baker RR
    Surg Gynecol Obstet; 1981 Jan; 152(1):70-4. PubMed ID: 7455895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
    Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
    Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of hormone receptors in the management of breast cancer--I. Advanced breast cancer.
    Cant EM; Horsfall D; Keightley DD
    Aust N Z J Surg; 1985 Apr; 55(2):121-5. PubMed ID: 3862384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Cancer; 1988 Jun; 61(11):2168-75. PubMed ID: 3130175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.